Intellectual disability



Zynerba Pharmaceuticals
Products and Services / Research

Zynerba Pharmaceuticals Initiates RECONNECT, a Pivotal Phase 3 Trial of Zygel in Fragile X Syndrome

- by MyChesCo

DEVON, PA — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE) announced the initiation of a pivotal, multinational randomized, double-blind, placebo-controlled, multiple-center, efficacy and safety (RECONNECT) Phase 3 trial.

Zynerba Pharmaceuticals Initiates RECONNECT, a Pivotal Phase 3 Trial of Zygel in Fragile X Syndrome Read More
PA Department of Human Services
Disabled Issues / Disabilities / Pennsylvania

Commonwealth Receives Federal Funding for Long-Term Services and Supports, Crisis Intervention for Individuals With Intellectual Disabilities and Autism

- by MyChesCo

HARRISBURG, PA — The Department of Human Services (DHS) announced that Pennsylvania will receive an estimated $12 million in federal reimbursement funding from the Centers for Medicare & Medicaid Services …

Commonwealth Receives Federal Funding for Long-Term Services and Supports, Crisis Intervention for Individuals With Intellectual Disabilities and Autism Read More

mental health
Mental Health / Pennsylvania

Role of Relationships, Social Support Systems for People with Intellectual and Developmental Disabilities, Autism and Mental Health and Behavioral Challenges

- by MyChesCo

HARRISBURG, PA — The Pennsylvania Department of Human Services (DHS) recently released the latest issue of the Positive Approaches Journal, which aims to provide the most recent research and resources for …

Role of Relationships, Social Support Systems for People with Intellectual and Developmental Disabilities, Autism and Mental Health and Behavioral Challenges Read More